Blog

Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.

Open filters
Search
Tags
Author
Alison Sathe
Anders Vinther
Barbara W. Unger
Jackie Torfin
Jerry Chapman
Jon Falker
Katie Terry
Mark Agostino
Rebecca Stauffer
Redica Systems
Roger Angarita
Sarah Boynton
Scott Sherrill
Subscribe to our Newsletter
Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.
Press Release

Govzilla and FOI Services Announce Strategic Partnership

No items found.
Enforcement

Why Did McKesson Receive the First DSCSA Warning Letter?

No items found.

FDA Form 483: A Helpful Guide to Proactive Compliance

No items found.
Enforcement

FDA Cites Part 11 in Clinical Trial

No items found.

FINAL Part 3: Who’s Who? Seeing CROs Clearly.

No items found.

Part 2: Who’s Who? Seeing CROs Clearly.

No items found.

Part 1: Who’s Who? Seeing CROs Clearly.

No items found.
Trends

FINAL Part 2: How to Stop the Data Integrity Excuses

No items found.

9 New Recalls | Week of November 4th 2018

No items found.
Conference Spotlight

49 New FDA 483s Added | November 12th 2018

API
Catalyst
Financial Services
Trends

Part 1: How to Stop the Data Integrity Excuses

No items found.

How to Respond to FDA 483s

No items found.
Enforcement

6 Features to Look for in FDA 483s

No items found.
Trends

“It was the Best Advice Because it was the Worst Advice”

No items found.
Trends

Why Isn’t Paper the Same as Electronic?

No items found.
Trends

FDA Draft Guidance on Multiple Entity Registration Requirements

No items found.

A Bad 483 Could Cost a Company Millions

No items found.
Trends

NASDA and FDA Work Together to Implement the Produce Safety Rule

No items found.